Market Overview:
Accrediting the kind of growth, the market is witnessing and the
growth prospect the market is demonstrating, Market Research Future (MRFR), has
recently published a brilliant study report. According to MRFR, the
Global Kidney Biopsy market
size is expected to perceive exponential growth USD 3.31 billion
by 2032, registering ~ 5.20% CAGR during the forecasted period 2023-2032.
The Kidney Biopsy Market is experiencing significant growth driven
by advancements in kidney biopsy procedures. As medical technologies evolve,
kidney biopsy procedures become more refined, offering clinicians a better
understanding of renal conditions and guiding appropriate treatment strategies.
This market expansion is also fueled by rising incidences of kidney diseases
globally, prompting increased demand for accurate diagnostic tools like kidney
biopsy procedures.
Kidney biopsy
procedures involve the extraction of a small
sample of kidney tissue for microscopic examination, aiding in the diagnosis of
various renal conditions such as glomerulonephritis, chronic kidney disease,
and kidney cancer. These procedures play a crucial role in determining the
severity and nature of renal diseases, enabling personalized treatment plans
for patients. With a growing emphasis on precision medicine, kidney biopsy
procedures are becoming indispensable tools in the management of renal
disorders, driving their adoption and contributing to the growth of the kidney
biopsy market. Additionally, ongoing research and development efforts aimed at
improving the safety and efficacy of kidney biopsy procedures are further
propelling market expansion, ensuring better patient outcomes and enhancing the
overall quality of care in nephrology.
Competitive Analysis
The global Kidney Biopsy market is a fragmented market
with many players. Product development strategy has been curtailed by the
excellent efficiency and efficacy of drugs. However, the rise of drug
resistance has opened doors for new drug development and is an opportunity for
a new market leader. The rise of spurious and counterfeit medicines has reduced
the total market revenues and at the same time displaced standard drugs off the
market.
Cook Medical (US), Boston Scientific Corporation (US), C R Bard,
Inc. (US), Hologic Inc. (US), Devicor Medical Products Inc. (US), Intact
Medical Corporation (US), Scion Medical Technologies LLC (US), Precision
Biopsy, LLC (US), Integra LifeSciences Corporation (US), Focal Therapeutics,
Inc. (US), Creganna (US), CareFusion (US), and Argon Medical Devices, Inc. (US)
are some of the prominent players profiled in MRFR Analysis and are at the
forefront of competition in the Global Market of Kidney Biopsy
Companies.
Segmentation-
For the convenience of the report and enhanced understanding; the
report - Kidney Biopsy Market is segmented in to 4 key dynamics.
By Types
: Comprises Percutaneous
and Surgical Biopsy.
By Indications
: Hematuria, Kidney Failure, Proteinuria, and Kidney Transplant.
By End Users
: Hospitals & Clinics, Tertiary Care Centers, & Urology Centers among
others.
By Regions
: North America, Europe, APAC, and Rest of the World.
Regional Analysis
Globally, North America is the largest market for the Kidney
Biopsies. Factors such as extensive uptake of technologically advanced medical
devices, high expenditures for health care coupled with the governmental
support for R&D activities drive the regional growth of the market.
Moreover, increasing prevalence of kidney diseases, diabetes, and renal failures
are providing impetus to the market growth.
While Europe region stands as the second-largest market for Kidney
Biopsies. This growth attributes to the increasing emphasis on the development
of advent urology diagnostic devices, rising government support for research
& development coupled with the availability of funds. Besides, rising
number of specialty services offered by various healthcare providers drive the
regional market growth.
However, the developing regions market particularly Asia Pacific
will be the fastest growing market for Kidney Biopsies. Factors such as the
ever-increasing prevalence of diabetes, and rising number of kidney transplant
procedures in urology centers, rapidly developing healthcare technology sector
and high healthcare expenditure drive the regional market growth. Furthermore,
increasing demand for quality devices in the healthcare is expected to lead the
use of advanced equipment, which, in turn, is expected to foster the market
growth in APAC region.
Related reports-
For more information, Please Visit us @ Market Research Future
No comments:
Post a Comment